Affiliation:
1. Department of Pharmaceutical Sciences, University Institute of Pharmacy, Pt. Ravishankar Shukla University Raipur, Chhattisgarh, 492010, India
2. Department of Pharmaceutical Sciences, Hemvati Nandan Bahuguna Garhwal University (A Central University), Chauras Campus, Tehri Garhwal, Uttarakhand, 249161, India
Abstract
Abstract:
Modern nanostructures must fulfill a wide range of functions to be valuable, leading to the combi-nation of various nano-objects into hierarchical assemblies. Hybrid Nanoparticles (HNPs), comprised of mul-tiple types of nanoparticles, are emerging as nanoscale structures with versatile applications. HNPs offer en-hanced medical benefits compared to basic combinations of distinct components. They address the limitations of traditional nanoparticle delivery systems, such as poor water solubility, nonspecific targeting, and subopti-mal therapeutic outcomes. HNPs also facilitate the transition from anatomical to molecular imaging in lung cancer diagnosis, ensuring precision. In clinical settings, the selection of nanoplatforms with superior repro-ducibility, cost-effectiveness, easy preparation, and advanced functional and structural characteristics is para-mount. This study aims toextensively examine hybrid nanoparticles, focusing on their classification, drug de-livery mechanisms, properties of hybrid inorganic nanoparticles, advancements in hybrid nanoparticle technol-ogy, and their biomedical applications, particularly emphasizing the utilization of smart hybrid nanoparticles. PHNPs enable the delivery of numerous anticancer, anti-leishmanial, and antifungal drugs, enhancing cellular absorption, bioavailability, and targeted drug delivery while reducing toxic side effects.
Publisher
Bentham Science Publishers Ltd.